These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19254917)

  • 1. Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion.
    Whelan BR; Isenberg DA
    Rheumatology (Oxford); 2009 May; 48(5):594-5. PubMed ID: 19254917
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.
    Valiyil R; Casciola-Rosen L; Hong G; Mammen A; Christopher-Stine L
    Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1328-34. PubMed ID: 20506493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab therapy in necrotizing autoimmune myopathy associated with anti-SRP antibody: A clinical case review.
    Nóvoa Medina FJ; Gutiérrez Martínez J; González González Y; Romero Díaz B; Machín García S; Rosas Romero A
    Reumatol Clin (Engl Ed); 2018; 14(6):379-381. PubMed ID: 28389200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of rituximab in refractory and relapsing myositis with anti-JO1 antibodies: a report of two cases.
    Frikha F; Rigolet A; Behin A; Fautrel B; Herson S; Benveniste O
    Rheumatology (Oxford); 2009 Sep; 48(9):1166-8. PubMed ID: 19549788
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of adult inflammatory myositis with rituximab: an emerging therapy for refractory patients.
    Majmudar S; Hall HA; Zimmermann B
    J Clin Rheumatol; 2009 Oct; 15(7):338-40. PubMed ID: 20009968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects for B-cell-targeted therapy in autoimmune disease.
    Edwards JC; Cambridge G
    Rheumatology (Oxford); 2005 Feb; 44(2):151-6. PubMed ID: 15509628
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases.
    Cooper N; Arnold DM
    Br J Haematol; 2010 Apr; 149(1):3-13. PubMed ID: 20151975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP).
    Arlet JB; Dimitri D; Pagnoux C; Boyer O; Maisonobe T; Authier FJ; Bloch-Queyrat C; Goulvestre C; Heshmati F; Atassi M; Guillevin L; Herson S; Benveniste O; Mouthon L
    Neuromuscul Disord; 2006 May; 16(5):334-6. PubMed ID: 16616848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell targeted therapy in autoimmunity.
    Blank M; Shoenfeld Y
    J Autoimmun; 2007; 28(2-3):62-8. PubMed ID: 17391915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-SRP auto-antibodies are not specific for myositis: Report of 8 cases.
    Rodríguez-Muguruza S; Lozano-Ramos I; Coll-Canti J; Hernández-Gallego A; Ojanguren I; Martinez-Caceres E; Olive A
    Joint Bone Spine; 2017 Jan; 84(1):103-105. PubMed ID: 27236258
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies.
    Suzuki S; Satoh T; Sato S; Otomo M; Hirayama Y; Sato H; Kawai M; Ishihara T; Suzuki N; Kuwana M
    Rheumatology (Oxford); 2008 Oct; 47(10):1539-42. PubMed ID: 18687709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating human autoimmune disease by depleting B cells.
    Looney RJ
    Ann Rheum Dis; 2002 Oct; 61(10):863-6. PubMed ID: 12228152
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-synthetase syndrome associated with anti PL-12 and anti-Signal recognition particle antibodies and a necrotizing auto-immune myositis.
    Malkan A; Cappelen-Smith C; Beran R; Griffith N; Toong C; Wang MX; Cordato D
    J Clin Neurosci; 2015 Feb; 22(2):396-8. PubMed ID: 25150763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-signal recognition particle autoantibody ELISA validation and clinical associations.
    Aggarwal R; Oddis CV; Goudeau D; Fertig N; Metes I; Stephens C; Qi Z; Koontz D; Levesque MC
    Rheumatology (Oxford); 2015 Jul; 54(7):1194-9. PubMed ID: 25524922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.
    Pinal-Fernandez I; Parks C; Werner JL; Albayda J; Paik J; Danoff SK; Casciola-Rosen L; Christopher-Stine L; Mammen AL
    Arthritis Care Res (Hoboken); 2017 Feb; 69(2):263-270. PubMed ID: 27111848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
    Guzman Moreno R
    Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-signal recognition particle autoantibody positive myopathy].
    Bodoki L; Vincze M; Hortobágyi T; Griger Z; Csonka T; Dankó K
    Ideggyogy Sz; 2014 Sep; 67(9-10):347-53. PubMed ID: 25518264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features and therapeutic response of our anti-SRP positive patients with myositis].
    Botos B; Nagy-Vincze M; Dankó K
    Orv Hetil; 2017 Sep; 158(35):1382-1389. PubMed ID: 28847176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-signal recognition particle-positive juvenile polymyositis successfully treated with rituximab.
    Luca NJ; Atkinson A; Hawkins C; Feldman BM
    J Rheumatol; 2012 Jul; 39(7):1483-5. PubMed ID: 22753802
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.
    Aggarwal R; Oddis CV; Goudeau D; Koontz D; Qi Z; Reed AM; Ascherman DP; Levesque MC
    Rheumatology (Oxford); 2016 Jun; 55(6):991-9. PubMed ID: 26888854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.